Abstracts / Abstrakts
- 30) Wellstein A, Palm D, Belz GG. ß-Adrenoceptor
subtype mediated effects in man in comparison to in vitro ß1
and ß2 adrenoceptor occupancy. Naunyn-Schmiedeberg's Arch Pharmacol
1986;322(Suppl.):R 78.
- 31) Tschollar W, Belz GG, Essig J, Runge J, Wellstein A. Fast
and safe blood pressure reduction from sublingual captopril. J Am
Coll Cardiol 1987;9:226A.
- 32) Belz GG, Essig J, Wellstein A. Schild plot
in man with the ACE-inhibitor cilazapril using angiotensin I
as agonist. Clin Pharmacol Ther 1987;41:232.
- 33) Darius H, Mohr-Kahaly S, Epperlein S, Belz GG. Pharmacodynamics
of captopril in antagonizing the effect of angiotensin I in
patients with valvular heart disease. Naunyn-Schmiedeberg's Arch
Pharmacol 1987;335(Suppl.):R 107.
- 34) Belz GG. Fendiline: Clinical Pharmacological
Profile of a Ca++-CaM-Antagonist.
J Mol Cell Cardiol 1987/88;19(Suppl.III):S 5.
- 35) Schäfer-Korting M, Meinicke T, Belz GG.The
relationship of enoximone pharmakokinethics and pharmacodynamics
in healthy man. Naunyn-Schmiedeberg's Arch Pharmacol 1988;337(Suppl.):R
120.
- 36) Breithaupt K, Belz GG, Fraedrich U, Stolzenburg K. Pharmacodynamic
properties of the PDE III inhibitor and Â1-antagonist
Saterinone (inn) in healthy volunteers. Naunyn-Schmiedeberg's
Arch Pharmacol 1988;338(Suppl.):R 78.
- 37) Schloos J, Wellstein A, Pitschner HF, Palm D, Belz
GG,Schäfer-Korting
M, Mutschler E. Carteolol (a ß-blocker with partial
agonistic activity) in comparison to propranolol as determined
by investigations in man and in vitro radioreceptor assays from
plasma samples. Naunyn-Schmiedeberg's Arch Pharmacol 1988;338(Suppl.):
R 78.
- 38) Bliesath H, Belz GG, Wurst W, Essig J, Steinijans VW,
Neumann B. The effect of 0.9 mg of Niguldipin i.v. on
blood pressure, heart rate, total peripheral resistance, and
cardiac output in healthy volunteers. J Cardiovasc Pharmacol 1988;12(Suppl.6):
S 213.
- 39) Beermann C, Kleinbloesem CH, Belz GG. Influence
of the angiotensin-converting enzyme inhibitor cilazapril and
the a1-receptor antagonist prazosin on the response of human hand
veins in situ to angiotensin I and noradrenaline. Naunyn-Schmiedeberg's
Arch Pharmacol 1989;339(Suppl.):R 72.
- 40) Belz GG, Beermann C, Schloos J, Kleinbloesem CH.Influence
of angiotensin-converting enzyme (ACE) inhibition on the response
of human hand veins in situ to angiotensin I and noradrenaline. Clin
Pharmacol Ther 1989;45:125.
- 41) Belz GG, Breithaupt K, Erb K, Kleinbloesem CH.Can
a combination of ACE-inhibitor and ß-blocker be successfully
used for treatment of hypertension. Clin Pharmacol Ther 1989;45:142.
- 42) Belz GG, Breithaupt K, Erb K, Schroeter V. Noninvasive
methods to measure cardiovascular drug actions. Europ J Clin Pharmacol
1989;36(Suppl.):A8.
< > 1 2 3 4 5 6 7 8 <